Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Clears First Sensor-Pill and App System

The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence. . . . → Read More: FDA Clears First Sensor-Pill and App System

Infographic: Largest Hacker Breaches and Regulation Tech

Among the most visible and challenging regulatory issues for companies is security breaches, where companies’ systems are attacked with valuable data stolen. . . . → Read More: Infographic: Largest Hacker Breaches and Regulation Tech

FDA Sets Genetic Health Test Review Process

The U.S. Food and Drug Administration is proposing new review requirements for genetic tests of health risks that providers market directly to consumers. . . . → Read More: FDA Sets Genetic Health Test Review Process

Infographic – Costs of Climate Change Soar

Our friends at Statista provide a look at the financial impact of climate change since 1990, just from extreme weather events. . . . → Read More: Infographic – Costs of Climate Change Soar

Report – 126 Alzheimer’s Drugs in Clinical Trials

A foundation supporting research on new drugs to treat Alzheimer’s disease says clinical trials now underway are testing 126 potential therapies for the disorder. . . . → Read More: Report – 126 Alzheimer’s Drugs in Clinical Trials

Cancer Drug Price Rises Shown Unrelated to Competition

An analysis of cancer drugs shows their prices steadily increased over 16 years despite competition from newer drugs on the market. . . . → Read More: Cancer Drug Price Rises Shown Unrelated to Competition

Here’s What a Real Opioid Emergency Looks Like

Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency. . . . → Read More: Here’s What a Real Opioid Emergency Looks Like

Blood-Thinning Drugs Linked with Lower Dementia Risk

People with irregular heart rhythms given anti-coagulation drugs to reduce their risk of stroke were also less likely to develop dementia than their counterparts not receiving blood-thinners. . . . → Read More: Blood-Thinning Drugs Linked with Lower Dementia Risk

Biosimilars Seen Saving U.S. $54 Billion

An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years. . . . → Read More: Biosimilars Seen Saving U.S. $54 Billion

Live Skin Bacteria Shown to Control Acne

First results of a clinical trial show a spray-on formulation of live bacteria reduced the amount and severity of acne in people with mild to moderate cases of the condition. . . . → Read More: Live Skin Bacteria Shown to Control Acne